These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study. Hyun MY; Son IP; Lee Y; Choi HG; Park KY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):278-282. PubMed ID: 24909188 [TBL] [Abstract][Full Text] [Related]
23. A medical alternative to the treatment of compensatory sweating. Cladellas E; Callejas MA; Grimalt R Dermatol Ther; 2008; 21(5):406-8. PubMed ID: 18844718 [TBL] [Abstract][Full Text] [Related]
24. Eccrine nevus affecting the forearm of an 11-year-old girl successfully controlled with topical glycopyrrolate. Dua J; Grabczynska S Pediatr Dermatol; 2014; 31(5):611-2. PubMed ID: 23534977 [TBL] [Abstract][Full Text] [Related]
25. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment. Prouty ME; Fischer R; Liu D Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329602 [TBL] [Abstract][Full Text] [Related]
26. Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis. Kumar MG; Foreman RS; Berk DR; Bayliss SJ Pediatr Dermatol; 2014; 31(1):e28-30. PubMed ID: 24266878 [TBL] [Abstract][Full Text] [Related]
27. Use of gloves when applying topical glycopyrronium for treatment of primary axillary hyperhidrosis. Siscos SM; Figenshau K; Rajpara A J Am Acad Dermatol; 2020 Oct; 83(4):e275. PubMed ID: 31846717 [No Abstract] [Full Text] [Related]
31. Pharmacology, toxicology and clinical safety of glycopyrrolate. Chabicovsky M; Winkler S; Soeberdt M; Kilic A; Masur C; Abels C Toxicol Appl Pharmacol; 2019 May; 370():154-169. PubMed ID: 30905688 [TBL] [Abstract][Full Text] [Related]
32. Treatment of diabetic gustatory sweating with topical glycopyrrolate cream. Atkin SL; Brown PM Diabet Med; 1996 May; 13(5):493-4. PubMed ID: 8737034 [TBL] [Abstract][Full Text] [Related]
33. [Topical glycopyrrolate in craniofacial hyperhidrosis]. Callejas MA; Grimalt R Med Clin (Barc); 2008 Jun; 131(4):157. PubMed ID: 18601830 [No Abstract] [Full Text] [Related]
34. Use of oral glycopyrronium bromide in hyperhidrosis. Bajaj V; Langtry JA Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043 [TBL] [Abstract][Full Text] [Related]
35. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis. Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203 [TBL] [Abstract][Full Text] [Related]
36. Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis. Del Boz J; Millán-Cayetano JF; Rivas-Ruiz F; de Troya-Martín M Br J Dermatol; 2017 Mar; 176(3):821-823. PubMed ID: 27436700 [No Abstract] [Full Text] [Related]
37. Mydriasis secondary to use of glycopyrrolate cream. Radotra A; Baneke A; Paul B Br J Hosp Med (Lond); 2019 Dec; 80(12):736. PubMed ID: 31822169 [No Abstract] [Full Text] [Related]
38. Diabetic gustatory sweating successfully treated with topical glycopyrrolate: report of a case and review of the literature. Urman JD; Bobrove AM Arch Intern Med; 1999 Apr; 159(8):877-8. PubMed ID: 10219935 [TBL] [Abstract][Full Text] [Related]
39. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Shaw JE; Abbott CA; Tindle K; Hollis S; Boulton AJ Diabetologia; 1997 Mar; 40(3):299-301. PubMed ID: 9084967 [TBL] [Abstract][Full Text] [Related]
40. Treating hyperhidrosis. Anticholinergic drugs were not mentioned. Klaber M; Catterall M BMJ; 2000 Sep; 321(7262):703. PubMed ID: 11202933 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]